Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,244 | -5,975 | -3,834 | -2,951 | -1,180 |
| Depreciation Amortization | 77 | 2,080 | 1,850 | 1,199 | 65 |
| Accounts receivable | -610 | -116 | -158 | 492 | 427 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -850 | N/A |
| Other Working Capital | -905 | -1,446 | -1,731 | -1,236 | -580 |
| Other Operating Activity | 610 | 127 | 158 | 357 | -427 |
| Operating Cash Flow | $-2,072 | $-5,331 | $-3,715 | $-2,987 | $-1,695 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -175 | -165 | -168 | -8 |
| Purchase Sale Intangibles | -99 | -662 | -621 | -595 | -205 |
| Other Investing Activity | -99 | -662 | -621 | -500 | -205 |
| Investing Cash Flow | $-105 | $-836 | $-786 | $-668 | $-212 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 4,748 | 4,024 | 4,024 | 355 |
| Other Financing Activity | 0 | 0 | 0 | -76 | 0 |
| Financing Cash Flow | $0 | $4,748 | $4,024 | $3,948 | $355 |
| Exchange Rate Effect | -34 | 856 | 97 | 326 | -10 |
| Beginning Cash Position | 9,123 | 9,687 | 9,687 | 9,687 | 9,687 |
| End Cash Position | 6,913 | 9,123 | 9,306 | 10,305 | 8,125 |
| Net Cash Flow | $-2,210 | $-563 | $-380 | $619 | $-1,562 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,072 | -5,331 | -3,715 | -2,987 | -1,695 |
| Capital Expenditure | -5 | -175 | -176 | -168 | -8 |
| Free Cash Flow | -2,077 | -5,506 | -3,891 | -3,155 | -1,703 |